Why is AORT down?
Up 4.4% today, while its medical device peers are down 0.3%; no story names it yet.
Down from its high
Down 53% from its Nov 12, 2025 high.
- Free cash flow went from $11.0M in fiscal 2024 to $839,000 in fiscal 2025.
AORT's Quality Score fell 2 points on Fri, Oct 30, to -3. Its daily swings widened out of the quietest 32.5% of the last 100 days (2 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 4.4% today, while its medical device peers are down 0.3%; no story names it yet.
Down from its high
Down 53% from its Nov 12, 2025 high.
| Holding it back | Below its 200-day since April |
| Latest filing | 10-Q, Aug 7 |
TodayNo story names it yet.
Tue Nov 10: Stifel Healthcare Conference 2026Investor conference · date confirmed.
1 more date ahead: the conference, for Pro members.
After its last 4 reports it closed -10.4% on average, higher 1 of 4 times.
Poorfor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means
AORT is #78 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 78 |
Reports Thu Nov 5, after the close (in 3 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
AORT's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Revenue | $480M to $496M |
Sales grew 12% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 4.5% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 6, 2026 | +1.2% | +2.1% | +6.9% |
| May 7, 2026 | -22.9% | -28.3% | -35.3% |
| Feb 12, 2026 | -4.2% | -10.0% | -5.7% |
Sales grew in six of the last seven years, to $441M in 2025. It turned a profit in 2025 after a loss in 2024.
4 insiders sold $2.6M across 7 filings in the last 6 months. No open-market buys on record. The newest:
5 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: AORT is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
“We face competition from several domestic and international medical device, pharmaceutical, and biopharmaceutical companies and from both for-profit and non-profit tissue processors.”
AORT scores -3 today, which Breakaway calls Poor. It is #78 of 85 in Medical Devices by Quality Score, with 1 of 14 chart checks firing. Down 53% from its Nov 12, 2025 high. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
AORT scores -3 today, which Breakaway calls Poor (below zero). That is #78 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind AORT's -3.
4 insiders sold $2.6M across 7 filings in the last 6 months. No open-market buys on record. The newest is Andrew M. Green, SVP, Regulatory and Quality, who sold $287K on Sep 10. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.